Dose finding study to assess the efficacy and safety of SK-PC-B70M in patients with mild to moderate Alzheimer's disease

Trial Profile

Dose finding study to assess the efficacy and safety of SK-PC-B70M in patients with mild to moderate Alzheimer's disease

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Jan 2010

At a glance

  • Drugs SK-PC-B70M (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Feb 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
    • 13 Nov 2008 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top